BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7174138)

  • 1. Neutrophil adherence during hemoperfusion in fulminant hepatic failure.
    Altin M; Hughes RD; Williams R
    Int J Artif Organs; 1982 Sep; 5(5):315-7. PubMed ID: 7174138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cytochemical changes and the adherence of neutrophil during cross-linked agarose encapsulated activated charcoal hemoperfusion.
    Chen GX; Shu CD; He J
    Biomater Artif Cells Immobilization Biotechnol; 1991; 19(1):277-81. PubMed ID: 1661186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of serial resin hemoperfusion in fulminant hepatic failure.
    Bihari D; Hughes RD; Gimson AE; Langley PG; Ede RJ; Eder G; Williams R
    Int J Artif Organs; 1983 Nov; 6(6):299-302. PubMed ID: 6668092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of inhibitors of brain Na+, K+-ATPase by hemoperfusion in fulminant hepatic failure.
    Seda HW; Hughes RD; Gove CD; Williams R
    Artif Organs; 1984 May; 8(2):174-8. PubMed ID: 6329147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of prostacyclin, PGI2, in the prevention of platelet aggregation during charcoal haemoperfusion.
    Langley PG; Hughes RD; Ton HY; Silk DB; Williams R
    Int J Artif Organs; 1979 Jul; 2(4):207-10. PubMed ID: 378864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats.
    Chang TM; Lister C; Chirito E; O'Keefe P; Resurreccion E
    Trans Am Soc Artif Intern Organs; 1978; 24():243-5. PubMed ID: 716006
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical, hematological and histological changes in a fulminant hepatic failure rat model for artificial liver assessment.
    Chirito E; Lister C; Chang TM
    Artif Organs; 1979 Feb; 3(1):42-6. PubMed ID: 435123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Earlier charcoal haemoperfusion in fulminant hepatic failure.
    Gimson AE; Braude S; Mellon PJ; Canalese J; Williams R
    Lancet; 1982 Sep; 2(8300):681-3. PubMed ID: 6126626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New apparatus for artificial liver support: PAT resin--removal of protein-bound substances and its effect on hepatic failure in animals].
    Omori Y
    Nihon Geka Gakkai Zasshi; 1985 May; 86(5):566-75. PubMed ID: 4021990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmaphoresis, charcoal, and resin perfusion in experimental porcine hepatic failure.
    Alp MH; Hickman R
    Dig Dis Sci; 1986 Feb; 31(2):181-7. PubMed ID: 3943446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hemoperfusion using coated bead-type charcoal on middle molecules of hepatic failure dogs.
    Nishiki M; Kawanishi H; Kanao M; Sugiyama M; Tsuchiya T; Ezaki H
    Hiroshima J Med Sci; 1984 Sep; 33(3):493-7. PubMed ID: 6511475
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemoperfusion based on artificial cells for aluminium and iron removal, immunosorption, fulminant hepatic failure, uremia, poisoning and metabolic assists.
    Chang TM
    Int J Artif Organs; 1986 Sep; 9(5):285-8. PubMed ID: 3781657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro blood compatibility studies on a new polymer-coated charcoal for haemoperfusion.
    Hughes RD; Langley PG; Williams R
    Int J Artif Organs; 1980 Sep; 3(5):277-9. PubMed ID: 7461861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum octopamine, coma, and charcoal haemoperfusion in fulminant hepatic failure.
    Chase RA; Trewby PN; Davis M; Williams R
    Eur J Clin Invest; 1977 Oct; 7(5):351-4. PubMed ID: 411665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiences in the treatment of fulminant hepatic failure by conservative therapy, charcoal haemoperfusion, and polyacrylonitrile haemodialysis.
    Silk DB; Williams R
    Int J Artif Organs; 1978 Jan; 1(1):29-33. PubMed ID: 669832
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of artificial liver support.
    Williams R; Ede R; Hughes R
    Int J Clin Pharmacol Res; 1985; 5(6):381-7. PubMed ID: 3005180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albumin-coated Amberlite XAD-7 resin for hemoperfusion in acute liver failure. Part II: in vivo evaluation.
    Hughes R; Ton HY; Langley P; Davies M; Hanid MA; Mellon P; Silk DB; Williams R
    Artif Organs; 1979 Feb; 3(1):23-6. PubMed ID: 435120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil adherence in chronic liver disease and fulminant hepatic failure.
    Altin M; Rajkovic IA; Hughes RD; Williams R
    Gut; 1983 Aug; 24(8):746-50. PubMed ID: 6873736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charcoal hemoperfusion for liver failure.
    Weston MJ
    Lancet; 1982 Oct; 2(8305):983. PubMed ID: 6127478
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet function in fulminant hepatic failure and effect of charcoal haemoperfusion.
    Weston MJ; Langley PG; Rubin MH; Hanid MA; Mellon P; Williams R
    Gut; 1977 Nov; 18(11):897-902. PubMed ID: 590850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.